PATENT CLAIM ANALYSIS

Application Number: 16045333
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-06
Patent Classification: ["514", "305000"]

Abstract:
Provided is a method for treating chronic obstructive pulmonary disease or chronic bronchitis, or inhibiting bronchospasm, which method comprises use of a powder inhaler to administer to a human patient in need of such treatment an effective amount of a powder inhalant, wherein the powder inhalant comprises 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropy1)-1-azoniabicyclo[2.2.2]octane bromide.

Claim (Index 47):
The method of  claim 36  further comprising administering an effective amount of a steroid.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 95.0
- Lexical Diversity: 1.38
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14712866', '15095036', '13011131', '13354873', '14311102']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7874178450138402
- 35 USC 102 Novelty (BERT): 0.5854582204632666
- Combined Prediction Score: 0.7672218825587828
- Mean Citation Score: 578.514324
- Max Citation Score: 585.7710599999998
- Similarity Product: 377.09665590233794

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test